Live feed17:19:35·2hINSIDERFilingvia QuantisnowChief Financial Officer Gabay Avraham sold $90,200 worth of shares (20,000 units at $4.51) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 861,076 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.ORMP· Oramed Pharmaceuticals Inc.Health CareOriginal source